Evidence map›Paper›PMID 28096372›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Helical structure, stability, and dynamics in human apolipoprotein E3 and E4 by hydrogen exchange and mass spectrometry.

Palaniappan S Chetty, Leland Mayne, Sissel Lund-Katz, S Walter Englander, Michael C Phillips

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Molecular dynamics simulation of apolipoprotein E3 lipid nanodiscs.Biochimica et biophysica acta. Biomembranes · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Orthogonal analysis of variants in APOE gene usingFrontiers in bioinformatics · 2023
    Article
  12. Review
  13. Review
  14. Apolipoprotein E and Atherosclerosis.Current atherosclerosis reports · 2021
    Review
  15. Review
  16. Review
  17. Article
  18. APOE in the normal brain.Neurobiology of disease · 2020
    Review
  19. Review
  20. Frontiers in aging neuroscience · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Palaniappan S ChettyDivision of Translational Medicine and Human Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104-5158.
Leland MayneThe Johnson Research Foundation, Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104.
Sissel Lund-KatzDivision of Translational Medicine and Human Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104-5158.
S Walter EnglanderThe Johnson Research Foundation, Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104 engl@mail.med.upenn.edu mcp3@mail.med.upenn.edu.ORCID 0000-0002-4802-2175
Michael C PhillipsDivision of Translational Medicine and Human Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104-5158; engl@mail.med.upenn.edu mcp3@mail.med.upenn.edu.
University of Pennsylvania · USJohnson Foundation · US

Funding

Protein structure and function by hydrogen exchange mass spectrometry analysisR01GM031847 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI ENGLANDER, S. WALTER · 1985 to 2017
$6.3M
NIGMS NIH HHS R01 GM031847
6 · The paper itself

Abstract

Apolipoprotein E (apoE) plays a critical role in cholesterol transport in both peripheral circulation and brain. Human apoE is a polymorphic 299-residue protein in which the less common E4 isoform differs from the major E3 isoform only by a C112R substitution. ApoE4 interacts with lipoprotein particles and with the amyloid-β peptide, and it is associated with increased incidence of cardiovascular and Alzheimer's disease. To understand the structural basis for the differences between apoE3 and E4 functionality, we used hydrogen-deuterium exchange coupled with a fragment separation method and mass spectrometric analysis to compare their secondary structures at near amino acid resolution. We determined the positions, dynamics, and stabilities of the helical segments in these two proteins, in their normal tetrameric state and in mutation-induced monomeric mutants. Consistent with prior X-ray crystallography and NMR results, the N-terminal domain contains four α-helices, 20 to 30 amino acids long. The C-terminal domain is relatively unstructured in the monomeric state but forms an α-helix ∼70 residues long in the self-associated tetrameric state. Helix stabilities are relatively low, 4 kcal/mol to 5 kcal/mol, consistent with flexibility and facile reversible unfolding. Secondary structure in the tetrameric apoE3 and E4 isoforms is similar except that some helical segments in apoE4 spanning residues 12 to 20 and 204 to 210 are unfolded. These conformational differences result from the C112R substitution in the N-terminal helix bundle and likely relate to a reduced ability of apoE4 to form tetramers, thereby increasing the concentration of functional apoE4 monomers, which gives rise to its higher lipid binding compared with apoE3.

Indexed as

Amino Acid SubstitutionApolipoprotein E3Apolipoprotein E4Circular DichroismGenetic Predisposition to DiseaseHydrogenHydrophobic and Hydrophilic InteractionsLipoproteinsMass SpectrometryMutation, MissensePoint MutationProtein BindingProtein DomainsProtein FoldingProtein IsoformsProtein MultimerizationApolipoprotein E3Apolipoprotein E4HydrogenLipoproteinsProtein IsoformsRecombinant Fusion Proteinsamphipathic helixapolipoprotein Echolesterolhydrogen exchange mass spectrometryprotein secondary structure

Identifiers

PMID28096372
PMCPMC5293021
OpenAlexW2574219503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.